We are live on ! Find out more
VFA

Values First Advisors Portfolio holdings

AUM $192M
1-Year Est. Return 24.96%
This Fund
S&P 500
This Quarter Est. Return
-0.29%
1 Year Est. Return
+24.96%
3 Year Est. Return
+70.52%
5 Year Est. Return
+87.3%
10 Year Est. Return
–
AUM
$139M
AUM Growth
-$1.6M
Cap. Flow
+$2.51M
Cap. Flow %
1.81%
Top 10 Hldgs %
29.02%
Holding
165
New
8
Increased
106
Reduced
38
Closed
9

Top Buys

Rank Stock Value
1
GTM
ZoomInfo Technologies
GTM
+$516K
2
DV icon
DoubleVerify
DV
+$495K
3
AAN
The Aaron's Company Inc
AAN
+$430K
4
EBS icon
Emergent Biosolutions
EBS
+$390K
5
MDB icon
MongoDB
MDB
+$356K

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$1.01M
2
DT icon
Dynatrace
DT
+$887K
3
NTUS
Natus Medical Inc
NTUS
+$418K
4
SMAR
Smartsheet Inc.
SMAR
+$334K
5
ASND icon
Ascendis Pharma A/S
ASND
+$313K

Sector Composition

Rank Sector Weight
1 Technology 14.9%
2 Healthcare 14.62%
3 Industrials 12.21%
4 Real Estate 6.65%
5 Financials 5.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATHX
151
DELISTED
Athersys, Inc. Common Stock
ATHX
$29K 0.02%
15,833
+521
+3% +$2.27K
ISMD icon
152
Inspire Small/Mid Cap Impact ETF
ISMD
$335M
$9K 0.01%
339
+1
+0.3% +$30
VMBS icon
153
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.4B
$7K 0.01%
156
– –
IEF icon
154
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
$6K ﹤0.01%
58
+1
+2% +$101
SCHH icon
155
Schwab US REIT ETF
SCHH
$11.7B
$3K ﹤0.01%
172
– –
DT icon
156
Dynatrace
DT
$12.1B
– –
-22,489
Closed -$887K
EPIX
157
DELISTED
ESSA Pharma
EPIX
– –
-14,605
Closed -$46K
NCNO icon
158
nCino
NCNO
$1.81B
– –
-9,128
Closed -$282K
SNPS icon
159
Synopsys
SNPS
$71.5B
– –
-718
Closed -$218K
SYY icon
160
Sysco
SYY
$39.7B
– –
-2,549
Closed -$216K
VCSH icon
161
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$0 ﹤0.01%
2
– –
SMAR
162
DELISTED
Smartsheet Inc.
SMAR
– –
-10,638
Closed -$334K
FRLN
163
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
– –
-3,753
Closed -$49K
NTUS
164
DELISTED
Natus Medical Inc
NTUS
– –
-12,769
Closed -$418K
BHVN
165
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-6,904
Closed -$1.01M
3 4 5 6
7

Similar funds

KWM
KRM Wealth Management Reno, Nevada $192M AUM
SCGDR
Sharp Capital Gestora de Recursos Rio De Janeiro, Brazil $192M AUM 42.07% 1-Year Est. Return
KC
Kintayl Capital New York $192M AUM 40.39% 1-Year Est. Return
CVSC
C.V. Starr & Co New York $192M AUM 35.69% 1-Year Est. Return
CA
Corrado Advisors Ramsey, New Jersey $192M AUM 20.53% 1-Year Est. Return
WIA
Westview Investment Advisors Burlington, Vermont $192M AUM
AGA
Arch Global Advisors New York $192M AUM
LFIA
Legacy Financial Independent Advisors Louisville, Kentucky $192M AUM

Values First Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Values First Advisors held 165 positions worth $139M, down 1.1% from $141M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Values First Advisors's Q3 2022 filing shows 8 new, 106 increased, 38 reduced and 9 closed positions. Its largest new stake was DoubleVerify: 19,213 shares worth $525K. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $1.01M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Industrials.

  • Values First Advisors's largest Q3 2022 buy was DoubleVerify: 19,213 shares worth $525K.
  • Values First Advisors added most to ZoomInfo Technologies in Q3 2022, an estimated $516K increase.
  • Values First Advisors's biggest Q3 2022 reduction was Ascendis Pharma A/S, cutting an estimated $313K.
  • Values First Advisors fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $1.01M.
  • Values First Advisors's ten largest holdings make up 29% of its $139M portfolio in Q3 2022.
  • Values First Advisors opened 8 new positions and closed 9 in Q3 2022.
  • Values First Advisors's portfolio value fell 1.1% quarter-over-quarter to $139M.

Based on Values First Advisors's 13F filing for Q3 2022, filed 2 Dec 2022.